Mariska Miranda

582 total citations
13 papers, 404 citations indexed

About

Mariska Miranda is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mariska Miranda has authored 13 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mariska Miranda's work include Cancer Cells and Metastasis (3 papers), DNA Repair Mechanisms (2 papers) and Neuroblastoma Research and Treatments (2 papers). Mariska Miranda is often cited by papers focused on Cancer Cells and Metastasis (3 papers), DNA Repair Mechanisms (2 papers) and Neuroblastoma Research and Treatments (2 papers). Mariska Miranda collaborates with scholars based in Australia, United States and Japan. Mariska Miranda's co-authors include Fares Al‐Ejeh, Kum Kum Khanna, Wei Shi, Sunil R. Lakhani, Peter T. Simpson, Georgia Chenevix‐Trench, Adrian P. Wiegmans, Jamie R. Kutasovic, Murugan Kalimutho and Kevin J. Spring and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and PLoS Genetics.

In The Last Decade

Mariska Miranda

12 papers receiving 401 citations

Peers

Mariska Miranda
Agnese Di Rocco United States
Min Soo Kim South Korea
Cheng Du China
Jonathan W. Haskins United States
Ashley L. Hein United States
Jacqueline Sayyah United States
Agnese Di Rocco United States
Mariska Miranda
Citations per year, relative to Mariska Miranda Mariska Miranda (= 1×) peers Agnese Di Rocco

Countries citing papers authored by Mariska Miranda

Since Specialization
Citations

This map shows the geographic impact of Mariska Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariska Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariska Miranda more than expected).

Fields of papers citing papers by Mariska Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariska Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariska Miranda. The network helps show where Mariska Miranda may publish in the future.

Co-authorship network of co-authors of Mariska Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Mariska Miranda. A scholar is included among the top collaborators of Mariska Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariska Miranda. Mariska Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Casciello, Francesco, Fares Al‐Ejeh, Mariska Miranda, et al.. (2020). G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome. Theranostics. 10(10). 4515–4529. 27 indexed citations
3.
Wiegmans, Adrian P., Jodi M. Saunus, Sunyoung Ham, et al.. (2019). Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer. JCI Insight. 5. 22 indexed citations
4.
Genz, Berit, Katharine M. Irvine, Jamie R. Kutasovic, et al.. (2019). Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells. Scientific Reports. 9(1). 8541–8541. 25 indexed citations
5.
Wiegmans, Adrian P., Mariska Miranda, Shu Wen, Fares Al‐Ejeh, & Andreas Möller. (2016). RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy. Oncotarget. 7(37). 60087–60100. 21 indexed citations
6.
Momeny, Majid, Reza Ghasemi, Giovanni Valenti, et al.. (2015). Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway. Tumor Biology. 37(3). 3913–3923. 14 indexed citations
7.
Miranda, Mariska, Esdy Rozali, Kum Kum Khanna, & Fares Al‐Ejeh. (2015). MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments. Oncoscience. 2(2). 99–101. 27 indexed citations
8.
Al‐Ejeh, Fares, Marina Pajic, Wei Shi, et al.. (2014). Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 20(12). 3187–3197. 31 indexed citations
9.
Al‐Ejeh, Fares, Peter T. Simpson, Kerenaftali Klein, et al.. (2014). Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. Oncogenesis. 3(4). e100–e100. 80 indexed citations
10.
Miranda, Mariska, Daniel L. Worthley, Kazutomo Togashi, et al.. (2014). The CIMP Phenotype inBRAFMutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort. Gastroenterology Research and Practice. 2014. 1–10. 39 indexed citations
11.
Al‐Ejeh, Fares, Mariska Miranda, Wei Shi, et al.. (2014). Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer. Oncotarget. 5(10). 3145–3158. 33 indexed citations
12.
Shi, Wei, Amanda L. Bain, Bjoern Schwer, et al.. (2013). Essential Developmental, Genomic Stability, and Tumour Suppressor Functions of the Mouse Orthologue of hSSB1/NABP2. PLoS Genetics. 9(2). e1003298–e1003298. 24 indexed citations
13.
Al‐Ejeh, Fares, Wei Shi, Mariska Miranda, et al.. (2013). Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor. Journal of Nuclear Medicine. 54(6). 913–921. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026